Search
for

    Glossary Endocrine Therapy-Induced Alopecia

    hair loss caused by treatments that alter hormone levels

    Endocrine Therapy-Induced Alopecia, also known as Hormone Therapy-Induced Alopecia, refers to hair loss that occurs as a side effect of treatments that alter hormone levels, commonly used in managing cancers like breast or prostate cancer. These therapies, such as tamoxifen or aromatase inhibitors, disrupt the normal hormonal balance, leading to thinning hair or baldness.

    Related Terms

    Sort by

    Research 30 of 1000+

    1. Endocrine Therapy–Induced Alopecia in Patients With Breast Cancer JAMA Dermatology · 2018 · 67 citations
    2. Minoxidil for Endocrine Therapy–Induced Alopecia in Women With Breast Cancer—Saint Agatha’s Blessing? JAMA Dermatology · 2018 · 9 citations
    3. Approaches to management of endocrine therapy–induced alopecia in breast cancer patients Supportive Care in Cancer · 2025 · 1 citations
    4. 51895 Interim Analysis of Platelet-Rich Plasma (PRP) Treatment for Endocrine Therapy-Induced Alopecia (EIA) and Permanent Chemotherapy-Induced Alopecia (pCIA) in Breast Cancer Patients: A Randomized Controlled Trial Journal of the American Academy of Dermatology · 2024
    5. 0478 Outcomes of oral dutasteride and oral minoxidil for treating endocrine therapy-induced alopecia from breast cancer treatment: A case series Journal of Investigative Dermatology · 2025
    6. The Use of Oral Dutasteride, Minoxidil, and Finasteride for Treating Endocrine Therapy-Induced Hair Loss from Breast Cancer Treatment: A Case Series Study JAAD Case Reports · 2025
    7. Efficacy of low-dose oral minoxidil in the management of anticancer therapy-induced alopecia in patients with breast cancer: A retrospective cohort study Journal of The American Academy of Dermatology · 2022
    8. Hair regrowth in endocrine therapy alopecia with dutasteride treatment in woman with estrogen positive breast cancer JAAD case reports · 2023
    9. CDK4/6 plus aromatase inhibitor-induced alopecia in breast cancer patients. Journal of Clinical Oncology · 2019 · 4 citations
    10. A case of aromatase inhibitor‐induced alopecia successfully treated with low‐dose oral minoxidil Journal of Cosmetic Dermatology · 2023
    11. Permanent chemotherapy-induced nonscarring alopecia and premature ovarian failure Clinical and Experimental Dermatology · 2015 · 5 citations
    12. Retrospective cohort study of CDK4/6-inhibitor-induced alopecia in breast cancer patients Supportive Care in Cancer · 2023 · 9 citations
    13. Assessment of Quality of Life and Treatment Outcomes of Patients With Persistent Postchemotherapy Alopecia JAMA Dermatology · 2019 · 43 citations
    14. Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies Breast Cancer Research and Treatment · 2018 · 22 citations
    15. Drugs and Androgenetic Alopecia: What to look out for 2024
    16. Permanent Alopecia in Breast Cancer Patients: Role of Taxanes and Endocrine Therapies Cutis · 2021 · 2 citations
    17. Retrospective cohort study of CDK4/6-inhibitor-induced alopecia in patients with breast cancer. Journal of Clinical Oncology · 2023
    18. [Systematic treatment with sex hormones in dermatology]. PubMed · 1976
    19. Persistent Alopecia in a Breast Cancer Patient Following Taxane Chemotherapy and Adjuvant Endocrine Therapy: Case Report and Review of Post-treatment Hair Loss in Oncology Patients with Breast Cancer Cureus · 2018 · 3 citations
    20. Impact of Reporter Type on Signal Detection of Cancer Therapy–Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System Preprints.org · 2026
    21. Impact of Reporter Type on Signal Detection of Cancer Therapy-Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System Pharmaceuticals · 2026
    22. Response to Kang et al, “Efficacy of low-dose oral minoxidil in the management of anticancer therapy-induced alopecia in patients with breast cancer: A retrospective cohort study” Journal of the American Academy of Dermatology · 2024 · 2 citations
    23. Clinical aspect, pathogenesis and therapy options of alopecia induced by hormonal therapy for breast cancer Exploration of targeted anti-tumor therapy · 2021 · 2 citations
    24. Present Chemotherapy Induced Alopecia and Research in Future Austin therapeutics · 2021
    25. Effect of Adenovirus-Mediated Expression of Sonic Hedgehog Gene on Hair Regrowth in Mice With Chemotherapy-Induced Alopecia JNCI: Journal of the National Cancer Institute · 2001 · 39 citations
    26. Pattern Alopecia during Hormonal Anticancer Therapy in Patients with Breast Cancer Annals of Dermatology · 2014 · 9 citations
    27. Generation of an integration-free human induced pluripotent stem cell line MUSIi010-A from occipital scalp fibroblasts of a male patient with androgenetic alopecia Stem Cell Research · 2019
    28. Alopecia in preexisting autoimmune thyroid disease in family medicine practice: can hyperprolactinemia induce hair loss? A case report Acta dermatovenerologica Alpina, Pannonica et Adriatica (Tiskana izd.) · 2021 · 1 citations
    29. Treatment of Chemotherapy Induced Alopecia IntechOpen eBooks · 2026
    30. Focal and Generalized Alopecia Veterinary Clinics of North America: Small Animal Practice · 1995 · 9 citations